Corrigendum to “α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration” [Neurobiol. Dis., Volume 105 (2017) Article 84, 98](S0969996117301201)(10.1016/j.nbd.2017.05.014);α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration

Neurobiology of Disease

Volumn 105, Issue , 2017, Pages 84-98

  Abdelmotilib, Hisham ^a   Maltbie, Tyler ^a   Delic, Vedad ^a   Liu, Zhiyong ^a   Hu, Xianzhen ^a   Fraser, Kyle B ^a   Moehle, Mark S ^a   Stoyka, Lindsay ^a   Anabtawi, Nadia ^a   Krendelchtchikova, Valentina ^a   Volpicelli Daley, Laura A ^a   West, Andrew ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Aggregation; NACP; Parkinson disease; Prion; SNCA

Indexed keywords

ALPHA SYNUCLEIN; ACETYLCHOLINESTERASE; DOPAMINE; ENOLASE; TAU PROTEIN; TYROSINE 3 MONOOXYGENASE;

AMYGDALA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DORSAL STRIATUM; ENTORHINAL CORTEX; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEWY BODY; MOUSE; NERVE DEGENERATION; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RODENT; SOMATOSENSORY CORTEX; SUBSTANTIA NIGRA PARS COMPACTA; ANIMAL; C3H MOUSE; C57BL MOUSE; CELL INCLUSION; CHEMICALLY INDUCED; CORPUS STRIATUM; DEGENERATIVE DISEASE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ACETYLCHOLINESTERASE; ALPHA-SYNUCLEIN; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INCLUSION BODIES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; NEURODEGENERATIVE DISEASES; NEURONS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TAU PROTEINS; TYROSINE 3-MONOOXYGENASE;

EID: 85019978351     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2021.105506     Document Type: Erratum

References (28)

1. Ayers, J.I., et al. Robust central nervous system pathology in transgenic mice following peripheral injection of alpha-Synuclein fibrils. J. Virol., 91, 2017.
2. Bousset, L., et al. An efficient procedure for removal and inactivation of alpha-Synuclein assemblies from laboratory materials. J. Parkinsons Dis. 6 (2016), 143–151.
3. Brahic, M., et al. Axonal transport and secretion of fibrillar forms of alpha-synuclein, Abeta42 peptide and HTTExon 1. Acta Neuropathol. 131 (2016), 539–548.
4. Fellner, L., et al. Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. Glia 61 (2013), 349–360.
5. Fitzpatrick, A.W., et al. Nanomechanics and intermolecular forces of amyloid revealed by four-dimensional electron microscopy. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 3380–3385.
6. Knowles, T.P., Buehler, M.J., Nanomechanics of functional and pathological amyloid materials. Nat. Nanotechnol. 6 (2011), 469–479.
7. Luk, K.C., et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20051–20056.
8. Luk, K.C., et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338 (2012), 949–953.
9. Luk, K.C., et al. Molecular and biological compatibility with host alpha-Synuclein influences fibril pathogenicity. Cell Rep. 16 (2016), 3373–3387.
10. Masuda-Suzukake, M., et al. Prion-like spreading of pathological alpha-synuclein in brain. Brain 136 (2013), 1128–1138.
11. Masuda-Suzukake, M., et al. Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol. Commun., 2, 2014, 88.
12. McDonald, A.J., Organization of amygdaloid projections to the prefrontal cortex and associated striatum in the rat. Neuroscience 44 (1991), 1–14.
13. Osterberg, V.R., et al. Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism. Cell Rep. 10 (2015), 1252–1260.
14. Paumier, K.L., et al. Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol. Dis. 82 (2015), 185–199.
15. Peelaerts, W., et al. Alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522 (2015), 340–344.
16. Poltorak, A., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998), 2085–2088.
17. Rey, N.L., et al. Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease. J. Exp. Med. 213 (2016), 1759–1778.
18. Sacino, A.N., et al. Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice. Acta Neuropathol. 127 (2014), 645–665.
19. Serpell, L.C., et al. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 4897–4902.
20. Spillantini, M.G., et al. Alpha-synuclein in Lewy bodies. Nature 388 (1997), 839–840.
21. Spillantini, M.G., et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251 (1998), 205–208.
22. Stefanova, N., et al. Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons. Am. J. Pathol. 179 (2011), 954–963.
23. Surmeier, D.J., et al. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18 (2017), 101–113.
24. Tarutani, A., et al. The effect of fragmented pathogenic alpha-Synuclein seeds on prion-like propagation. J. Biol. Chem. 291 (2016), 18675–18688.
25. Thomzig, A., et al. Decontamination of medical devices from pathological amyloid-beta-, tau- and alpha-synuclein aggregates. Acta Neuropathol. Commun., 2, 2014, 151.
26. Volpicelli-Daley, L.A., et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72 (2011), 57–71.
27. Volpicelli-Daley, L.A., et al. G2019S-LRRK2 expression augments alpha-Synuclein sequestration into inclusions in neurons. J. Neurosci. 36 (2016), 7415–7427.
28. Wilhelm, B.G., et al. Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344 (2014), 1023–1028.